Pilot clinical study for quantitative spectral diagnosis of non-melanoma skin cancer.
BACKGROUND
Several research groups have demonstrated the non-invasive diagnostic potential of diffuse optical spectroscopy (DOS) and laser-induced fluorescence (LIF) techniques for early cancer detection. By combining both modalities, one can simultaneously measure quantitative parameters related to the morphology, function and biochemical composition of tissue and use them to diagnose malignancy. The objective of this study was to use a quantitative reflectance/fluorescence spectroscopic technique to determine the optical properties of normal skin and non-melanoma skin cancers and the ability to accurately classify them. An additional goal was to determine the ability of the technique to differentiate non-melanoma skin cancers from normal skin.


METHODS
The study comprised 48 lesions measured from 40 patients scheduled for a biopsy of suspected non-melanoma skin cancers. White light reflectance and laser-induced fluorescence spectra (wavelength range = 350-700 nm) were collected from each suspected lesion and adjacent clinically normal skin using a custom-built, optical fiber-based clinical instrument. After measurement, the skin sites were biopsied and categorized according to histopathology. Using a quantitative model, we extracted various optical parameters from the measured spectra that could be correlated to the physiological state of tissue.


RESULTS
Scattering from cancerous lesions was significantly lower than normal skin for every lesion group, whereas absorption parameters were significantly higher. Using numerical cut-offs for our optical parameters, our clinical instrument could classify basal cell carcinomas with a sensitivity and specificity of 94% and 89%, respectively. Similarly, the instrument classified actinic keratoses and squamous cell carcinomas with a sensitivity of 100% and specificity of 50%.


CONCLUSIONS
The measured optical properties and fluorophore contributions of normal skin and non-melanoma skin cancers are significantly different from each other and correlate well with tissue pathology. A diagnostic algorithm that combines these extracted properties holds promise for the potential non-invasive diagnosis of skin cancer.
Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, USA.
Narasimhan
N
Rajaram
Jason S
JS
Reichenberg
Michael R
MR
Migden
Tri H
TH
Nguyen
James W
JW
Tunnell
D002277:Carcinoma / Q000175:diagnosis*; D006801:Humans; D054025:Lasers, Dye; D054020:Lasers, Gas; D010865:Pilot Projects; D011237:Predictive Value of Tests; D012878:Skin Neoplasms / Q000175:diagnosis*; D013050:Spectrometry, Fluorescence
J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):8-10
10607350
J Biomed Opt. 2008 Jan-Feb;13(1):014017
18315375
Stat Med. 1997 Dec 30;16(24):2813-27
9483716
Photochem Photobiol. 2001 Jun;73(6):636-41
11421069
Opt Lett. 2002 Feb 15;27(4):246-8
18007768
Opt Lett. 2000 Oct 1;25(19):1451-3
18066245
J Biomed Opt. 2008 Sep-Oct;13(5):050501
19021373
Australas J Dermatol. 2007 May;48(2):77-82
17535192
Neoplasia. 2000 Jan-Apr;2(1-2):89-117
10933071
Photochem Photobiol. 2001 Feb;73(2):178-83
11272732
Photochem Photobiol. 1992 Apr;55(4):515-22
1620728
Appl Opt. 2004 May 1;43(13):2643-50
15130003
Br J Dermatol. 2006 Jul;155(1):100-3
16792759
Clin Dermatol. 2004 May-Jun;22(3):189-96
15262304
Cancer Res. 2002 Feb 1;62(3):682-7
11830520
Phys Med Biol. 2000 Mar;45(3):735-51
10730968
J Biomed Opt. 2008 Mar-Apr;13(2):024017
18465980
J Natl Cancer Inst. 1990 Jan 3;82(1):4-6
1688381
Opt Express. 2008 Sep 15;16(19):14961-78
18795033
J Biomed Opt. 2008 Mar-Apr;13(2):024013
18465976
J Biomed Opt. 2005 Nov-Dec;10(6):064020
16409085
Lasers Surg Med. 2002;31(5):367-73
12430156
South Med J. 2000 Jul;93(7):650-5
10923948
Lancet Oncol. 2002 Mar;3(3):159-65
11902502
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19494-9
18042710
J Biomed Opt. 2008 Mar-Apr;13(2):024012
18465975
Am J Obstet Gynecol. 2002 Mar;186(3):374-82
11904594
IEEE Trans Biomed Eng. 2003 Nov;50(11):1233-42
14619993
J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):4-7
10607349
J Gen Intern Med. 2006 Jul;21(7):678-82
16808765
Lasers Surg Med. 2010 Sep;42(7):680-8
20740619
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
20610543
Lasers Surg Med. 2008 Sep;40(7):461-7
18727020
Opt Lett. 2004 May 15;29(10):1087-9
15181994
J Biomed Opt. 2005 Mar-Apr;10(2):024032
15910105
Cancer. 2003 Apr 1;97(7):1681-92
12655525
J Biomed Opt. 2007 May-Jun;12(3):034027
17614735
Appl Opt. 1997 Feb 1;36(4):949-57
18250760
J Biomed Opt. 2006 Nov-Dec;11(6):064026
17212549
J Biomed Opt. 2008 May-Jun;13(3):034015
18601560
J Biomed Opt. 2007 May-Jun;12(3):034004
17614712
Skin Res Technol. 2008 Aug;14(3):364-9
19159385
Appl Opt. 2010 Jan 10;49(2):142-52
20062500
Melanoma Res. 2000 Dec;10(6):563-70
11198478